Click to see the March-April 2009 RevitaLash^® Newsletter
http://www.revitalashnewsletter.com

View our ARCHIVE

New Beauty Magazine’s Winter/Spring 2009 issue discusses Hair Loss at length in their Hair section on Page 152 saying, “Weak hair can result from a variety of factors – regardless of your hair’s natural texture – like an improper diet, styling abuse and even washing too frequently. Diligent use of reconstructive products and treatments are best for adding strength and resilience to your strands, making them stronger and healthier with time.”

New Beauty’s solutions for thicker, healthier hair continue, “With age, our hair naturally begins to thin out, becoming finer and weaker. And, like most women, chances are that your hair will start to gray as it ages, a sign that hair is definitely in need of color. But since the diameter of an aging hair is more narrow, it’s often recommended to leave chemical products like color, perms and straightening solutions on the hair for less time than usual.

FOR IMMEDIATE RELEASE

CONTACT: Roz May

818.508.0242

rozmaypr@gmail.com

Athena Cosmetics, Inc. today announced a donation of $10,000 to support forward-looking research projects, including the Tumor Vaccine Group at the University of Washington. This contribution makes the latest in the company’s on-going commitment to fight Breast Cancer.

Since the company launched its first product, RevitaLash®, this mission has been in the hearts and minds of everyone at the company. Gayle Brinkenhoff, wife of Dr. Michael Brinkenhoff who created RevitaLash®, is a breast cancer patient and survivor. So, supporting breast cancer initiatives is of paramount importance to the company.

“Athena Cosmetics, Inc. is committed to using a portion of our corporate profits to support breast cancer research and educational initiatives,” states Michael Brinkenhoff, M.D., President. ‘We are excited and impressed with the University of Washington’s Tumor Vaccine Group and its mission to conduct basic and clinical cancer research that leads to the development of effective immune-based cancer therapies. Their work with the multi-antigen breast cancer vaccine program is particularly promising and we are delighted to contribute towards its success.”

The groundbreaking work at the Tumor Vaccine Group emphasizes translational research, which means that under one roof efforts are moved from the lab bench to the bedside. “Our integrative research approach is gaining wider recognition throughout the cancer research community,” comments Nora Disis, M.D., Principal Investigator. “We appreciate Athena Cosmetics commitment to breast cancer research, and their support in helping us generate novel approaches to cancer treatment.”

RevitaLash® is a cosmetic eyelash conditioner that has been used by thousands of satisfied customers for over two years. RevitaLash® Eyelash Conditioner was developed by an ophthalmologist who was motivated to create a safe cosmetic product to enhance the beauty and attractiveness of women’s natural eyelashes after his wife’s eyelashes were devastated by chemotherapy treatments for breast cancer.

To honor its beginnings, Athena Cosmetics, Inc. contributes a portion of the proceeds from sales of RevitaLash® to support breast cancer research and educational initiatives.

Athena Cosmetics, Inc. was established in November, 2006. RevitaLash® Eyelash Conditioner, the company’s original product, has received an overwhelmingly positive response from women around the world. RevitaLash® can be found in more than 5,000 physician’s offices, premium spas and salons across the country and around the world. Other Athena Cosmetics products include Hair by Revitalash® and Mascara by Revitalash®.